← Back to Clinical Trials
Recruiting NCT07081568

NCT07081568 Research on Binaural Synchronous Vagus Nerve Regulation of Sensorimotor Disorders After Cerebral Infarction

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07081568
Status Recruiting
Phase
Sponsor Nanchang University Affiliated Rehabilitation Hospital
Condition Cerebral Infarction
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2025-06-25
Primary Completion 2027-06-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 80 Years
Study Type INTERVENTIONAL
Interventions
transcutaneous auriculai vagus nerve stimulation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 40 participants in total. It began in 2025-06-25 with a primary completion date of 2027-06-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of this study is to determine the efficacy and safety of binaural synchronous vagus nerve regulation in the treatment of patients with sensory and motor dysfunction after cerebral infarction through a randomized controlled clinical study, and to provide high-quality evidence support for binaural synchronous vagus nerve regulation in the treatment of cerebral infarction.

Eligibility Criteria

Inclusion Criteria: * Patients with first-episode ischemic stroke within 7 to 14 days of onset; * Be over 18 years old; * The skin at the irritated area remains intact; * The informed consent form has been signed. Exclusion Criteria: * Severe cognitive dysfunction (Mini-Mental State Examination≥19); * Peripheral limb movement limiting factors (fractures); * History of major neurological and mental disorders in the past; * Uncontrollable limb and facial muscle twitching, and spontaneous profuse sweating; * Intracranial shunt pumps, metal implants

Contact & Investigator

Central Contact

Han Jinjing Attending Physician

✉ 515476321@qq.com

📞 13672202061

Frequently Asked Questions

Who can join the NCT07081568 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Cerebral Infarction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07081568 currently recruiting?

Yes, NCT07081568 is actively recruiting participants. Contact the research team at 515476321@qq.com for enrollment information.

Where is the NCT07081568 trial being conducted?

This trial is being conducted at Nanchang, China.

Who is sponsoring the NCT07081568 clinical trial?

NCT07081568 is sponsored by Nanchang University Affiliated Rehabilitation Hospital. The trial plans to enroll 40 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology